93 related articles for article (PubMed ID: 21397967)
1. Motion-weighted target volume and dose-volume histogram: a practical approximation of four-dimensional planning and evaluation.
Zhang G; Feygelman V; Huang TC; Stevens C; Li W; Dilling T
Radiother Oncol; 2011 Apr; 99(1):67-72. PubMed ID: 21397967
[TBL] [Abstract][Full Text] [Related]
2. A novel four-dimensional radiotherapy planning strategy from a tumor-tracking beam's eye view.
Li G; Cohen P; Xie H; Low D; Li D; Rimner A
Phys Med Biol; 2012 Nov; 57(22):7579-98. PubMed ID: 23103415
[TBL] [Abstract][Full Text] [Related]
3. Four-dimensional treatment planning for stereotactic body radiotherapy.
Guckenberger M; Wilbert J; Krieger T; Richter A; Baier K; Meyer J; Flentje M
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):276-85. PubMed ID: 17707282
[TBL] [Abstract][Full Text] [Related]
4. Four-dimensional radiotherapy planning for DMLC-based respiratory motion tracking.
Keall PJ; Joshi S; Vedam SS; Siebers JV; Kini VR; Mohan R
Med Phys; 2005 Apr; 32(4):942-51. PubMed ID: 15895577
[TBL] [Abstract][Full Text] [Related]
5. The relative accuracy of 4D dose accumulation for lung radiotherapy using rigid dose projection versus dose recalculation on every breathing phase.
Valdes G; Lee C; Tenn S; Lee P; Robinson C; Iwamoto K; Low D; Lamb JM
Med Phys; 2017 Mar; 44(3):1120-1127. PubMed ID: 28019649
[TBL] [Abstract][Full Text] [Related]
6. [Internal target volume definition using four-dimensional CT and dosimetric evaluation for hepatocellular carcinoma].
Xi M; Liu MZ; Deng XW; Liu H; Huang XY; Zhang L; Li QQ; Hu YH; Cai L; Cui NJ
Ai Zheng; 2007 Jan; 26(1):1-8. PubMed ID: 17222359
[TBL] [Abstract][Full Text] [Related]
7. Four-dimensional image-based treatment planning: Target volume segmentation and dose calculation in the presence of respiratory motion.
Rietzel E; Chen GT; Choi NC; Willet CG
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1535-50. PubMed ID: 15817360
[TBL] [Abstract][Full Text] [Related]
8. Tumor control probability and the utility of 4D vs 3D dose calculations for stereotactic body radiotherapy for lung cancer.
Valdes G; Robinson C; Lee P; Morel D; Low D; Iwamoto KS; Lamb JM
Med Dosim; 2015; 40(1):64-9. PubMed ID: 25542785
[TBL] [Abstract][Full Text] [Related]
9. Dose calculations accounting for breathing motion in stereotactic lung radiotherapy based on 4D-CT and the internal target volume.
Admiraal MA; Schuring D; Hurkmans CW
Radiother Oncol; 2008 Jan; 86(1):55-60. PubMed ID: 18082905
[TBL] [Abstract][Full Text] [Related]
10. A novel concept to include uncertainties in the evaluation of stereotactic body radiation therapy after 4D dose accumulation using deformable image registration.
Azcona JD; Huesa-Berral C; Moreno-Jiménez M; Barbés B; Aristu JJ; Burguete J
Med Phys; 2019 Oct; 46(10):4346-4355. PubMed ID: 31402461
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric Consequences of 3D Versus 4D PET/CT for Target Delineation of Lung Stereotactic Radiotherapy.
Siva S; Chesson B; Callahan JW; Hardcastle N; Crawford L; Antippa P; Wright G; MacManus MP; Hicks RJ; Kron T; Ball DL
J Thorac Oncol; 2015 Jul; 10(7):1112-5. PubMed ID: 26134229
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric Benefits of Midposition Compared With Internal Target Volume Strategy for Esophageal Cancer Radiation Therapy.
Jin P; Machiels M; Crama KF; Visser J; van Wieringen N; Bel A; Hulshof MCCM; Alderliesten T
Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):491-502. PubMed ID: 30253234
[TBL] [Abstract][Full Text] [Related]
13. Potential dosimetric benefits of four-dimensional radiation treatment planning.
Starkschall G; Britton K; McAleer MF; Jeter MD; Kaus MR; Bzdusek K; Mohan R; Cox JD
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1560-5. PubMed ID: 19231098
[TBL] [Abstract][Full Text] [Related]
14. Estimation of the delivered patient dose in lung IMRT treatment based on deformable registration of 4D-CT data and Monte Carlo simulations.
Flampouri S; Jiang SB; Sharp GC; Wolfgang J; Patel AA; Choi NC
Phys Med Biol; 2006 Jun; 51(11):2763-79. PubMed ID: 16723765
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of dosimetric misrepresentations from 3D conventional planning of liver SBRT using 4D deformable dose integration.
Yeo UA; Taylor ML; Supple JR; Siva S; Kron T; Pham D; Franich RD
J Appl Clin Med Phys; 2014 Nov; 15(6):4978. PubMed ID: 25493523
[TBL] [Abstract][Full Text] [Related]
16. [4D-CT-based plan target volume (PTV) definition compared with conventional PTV definition using general margin in radiotherapy for lung cancer].
Ju X; Li M; Zhou Z; Zhang K; Han W; Fu G; Cao Y; Wang L
Zhonghua Zhong Liu Za Zhi; 2014 Jan; 36(1):34-8. PubMed ID: 24685084
[TBL] [Abstract][Full Text] [Related]
17. Lung 4D-IMRT treatment planning: an evaluation of three methods applied to four-dimensional data sets.
Ehler ED; Tomé WA
Radiother Oncol; 2008 Sep; 88(3):319-25. PubMed ID: 18703249
[TBL] [Abstract][Full Text] [Related]
18. Impact of temporal probability in 4D dose calculation for lung tumors.
Rouabhi O; Ma M; Bayouth J; Xia J
J Appl Clin Med Phys; 2015 Nov; 16(6):110-118. PubMed ID: 26699562
[TBL] [Abstract][Full Text] [Related]
19. A novel four-dimensional radiotherapy method for lung cancer: imaging, treatment planning and delivery.
Alasti H; Cho YB; Vandermeer AD; Abbas A; Norrlinger B; Shubbar S; Bezjak A
Phys Med Biol; 2006 Jun; 51(12):3251-67. PubMed ID: 16757875
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage.
Wang L; Hayes S; Paskalev K; Jin L; Buyyounouski MK; Ma CC; Feigenberg S
Radiother Oncol; 2009 Jun; 91(3):314-24. PubMed ID: 19111362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
